AOCI at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.
The official record: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Cogent Biosciences, Inc.'s aoci.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Cogent Biosciences, Inc.'s AOCI?
- Cogent Biosciences, Inc. (COGT) reported AOCI of -$415K in Q1 2026.
- How has Cogent Biosciences, Inc.'s AOCI changed year-over-year?
- Cogent Biosciences, Inc.'s AOCI decreased by 353.0% year-over-year, from $164K to -$415K.
- What is the long-term trend for Cogent Biosciences, Inc.'s AOCI?
- Over 3 years (2022 to 2025), Cogent Biosciences, Inc.'s AOCI has grown at a 50.6% compound annual growth rate (CAGR), from -$104K to $355K.
- What does AOCI mean?
- Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.